[{"address1": "955 Chesterbrook Boulevard", "address2": "Suite 110", "city": "Chesterbrook", "state": "PA", "zip": "19087", "country": "United States", "phone": "610 354 8840", "website": "https://www.trevena.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Ms. Carrie L. Bourdow", "age": 60, "title": "President, CEO & Chairman", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 1083155, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Barry  Shin", "age": 51, "title": "Executive VP, COO & CFO", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 722788, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark A. Demitrack M.D.", "age": 65, "title": "Senior VP & Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 741345, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Howard A. Rockman M.D.", "title": "Scientific Founder, Consultant and Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joel  Solomon", "title": "VP, General Counsel, Company Secretary & Chief Compliance Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Catalano", "title": "Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert T. Yoder", "age": 57, "title": "Senior VP, Chief Business Officer & Head of Commercial Operations", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 490639, "exercisedValue": 0, "unexercisedValue": 9545}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.211, "open": 0.208, "dayLow": 0.2079, "dayHigh": 0.225, "regularMarketPreviousClose": 0.211, "regularMarketOpen": 0.208, "regularMarketDayLow": 0.2079, "regularMarketDayHigh": 0.225, "beta": 1.051, "forwardPE": -0.15817519, "volume": 308342, "regularMarketVolume": 308342, "averageVolume": 941663, "averageVolume10days": 915710, "averageDailyVolume10Day": 915710, "bid": 0.1575, "ask": 0.2748, "bidSize": 200, "askSize": 200, "marketCap": 3974494, "fiftyTwoWeekLow": 0.191, "fiftyTwoWeekHigh": 1.12, "priceToSalesTrailing12Months": 1.2661656, "fiftyDayAverage": 0.3635, "twoHundredDayAverage": 0.52559, "currency": "USD", "enterpriseValue": 16933484, "floatShares": 16589392, "sharesOutstanding": 18341000, "sharesShort": 50453, "sharesShortPriorMonth": 20335, "sharesShortPreviousMonthDate": 1715731200, "dateShortInterest": 1718323200, "sharesPercentSharesOut": 0.0028, "heldPercentInsiders": 0.00922, "heldPercentInstitutions": 0.121759996, "shortRatio": 0.82, "shortPercentOfFloat": 0.0028, "bookValue": -0.8, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -40148000, "trailingEps": -2.71, "forwardEps": -1.37, "enterpriseToRevenue": 5.395, "enterpriseToEbitda": -0.488, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "TRVN", "underlyingSymbol": "TRVN", "shortName": "Trevena, Inc.", "longName": "Trevena, Inc.", "firstTradeDateEpochUtc": 1391178600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ab31c962-bf5d-3c6b-b3ee-f6b5d965694f", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.2167, "targetHighPrice": 5.0, "targetLowPrice": 3.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 23552000, "totalCashPerShare": 1.284, "ebitda": -34707000, "totalDebt": 36511000, "quickRatio": 3.268, "currentRatio": 3.605, "totalRevenue": 3139000, "revenuePerShare": 0.2, "returnOnAssets": -0.63098997, "freeCashflow": -21141750, "operatingCashflow": -31581000, "revenueGrowth": 2.333, "grossMargins": 0.48041, "operatingMargins": -493.9, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-08"}]